Your session is about to expire
Study Summary
This trial is testing the effectiveness of a new type of radiation therapy called TrueBeam in treating prostate cancer. The hope is that this new therapy will be more effective in treating the tumor while minimizing injury to nearby healthy tissue.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Local control
Side effects data
From 2008 Phase 2 trial • 20 Patients • NCT0035014215%
ulcer
10%
vomiting
5%
Perforation
5%
pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
SBRT With Gem
Trial Design
1Treatment groups
Experimental Treatment
Group I: ObservationExperimental Treatment1 Intervention
Observational study of patient efficacy and side effects
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stereotactic Body Radiotherapy
2017
Completed Phase 2
~220
Find a Location
Who is running the clinical trial?
Linda Chan, MDLead Sponsor
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available vacancies for this research endeavor?
"Data accessible on clinicaltrials.gov reports that this trial is in its recruitment stage, with the first post being made on June 5th 2018 and the last update taking place November 3rd 2022."
Answered by AI
What is the current cohort size of this research study?
"Affirmative. Clinicaltrials.gov's data suggests that this research endeavor, which was initially posted on June 5th 2018, is currently soliciting participants. Approximately 167 individuals must be recruited from a single center."
Answered by AI
Share this study with friends
Copy Link
Messenger